首页Healthluckotheirishmegaways| Olin Bio: Quadrivalent influenza virus split vaccine (MDCK cells) approved for clinical trials

luckotheirishmegaways| Olin Bio: Quadrivalent influenza virus split vaccine (MDCK cells) approved for clinical trials

时间2024-05-15 20:21:31分类Health浏览3
导读:News summary [Olin Bio: Quadrivalent influenza virus split vaccine (MDCK cells approved for clinical trials] Securities......

News summary

[Olin Bio: Quadrivalent influenza virus split vaccine (MDCK cells) approved for clinical trials] Securities Times e Company NewsluckotheirishmegawaysOlin Biotech (688319) announced on the evening of May 15 that recently, the company received approval from the State Food and Drug Administration for the issuance of a tetravalent influenza virus split vaccine (MDCK cells)luckotheirishmegaways...

luckotheirishmegaways| Olin Bio: Quadrivalent influenza virus split vaccine (MDCK cells) approved for clinical trials

Newsletter text

[Olin Biological: Quadrivalent influenza virus split vaccine (MDCK cells) has been approved for clinical trials] Securities Times e Company News, Olin Biotech (688319) announced on the evening of May 15 that recently, the company received approval and issuance from the State Food and Drug Administration. The "Drug Clinical Trial Approval Notice" for the Quadrivalent influenza virus split vaccine (MDCK cells) agrees to conduct clinical trials to prevent influenza caused by vaccine-related types of influenza viruses in people aged 6 months and above.

onlinecasinobonus| Beihua Co., Ltd.: There have been no major changes in the company's internal and external operating environment Tiger'sRoar| Gu Yu, Vice President of Jingdong Group, visited Shanghai Trading Group